Oral Health in Breast Cancer Survivors on Aromatase Inhibitors
This cross-sectional prevalence study seeks to investigate the incidence and severity of
oral health changes, specifically of periodontal conditions, among breast cancer survivors
and the ways in which these outcomes affect their quality of life.
- To determine the prevalence and severity of oral conditions in postmenopausal women
with early stage breast cancer using adjuvant AI therapy as compared to postmenopausal
women not using adjuvant AI therapy.
- To determine if adjuvant AI therapy use is associated with greater alveolar bone loss
or increased levels of bone turnover biomarkers in postmenopausal women with cancer
undergoing adjuvant AI therapy compared to postmenopausal women not receiving AI
- To determine the oral health-related quality of life among postmenopausal women with
early stage breast cancer who are receiving adjuvant AI therapy.
Time Perspective: Cross-Sectional
At the time of study visit
L. Susan Taichman, RDH MPH PhD
University of Michigan
United States: Institutional Review Board
|Michigan Center For Oral Health Research (MCOHR)||Ann Arbor, Michigan 48106|